Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 5/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

100%

3 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

Phase 4
3(100.0%)
3Total
Phase 4(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT05482789Phase 4Recruiting

Exenatide Pharmacokinetics and Pharmacodynamics in Gestational Diabetes

Role: lead

NCT03570632Phase 4Active Not Recruiting

Metformin for Preeclampsia Prevention in Pregnant Women With Type 1 Diabetes Mellitus

Role: lead

NCT03029702Phase 4Completed

Metabolic Analysis for Treatment Choice in Gestational Diabetes Mellitus

Role: lead

All 3 trials loaded